Wednesday, February 6, 2019

recommended the approval

Only an alleged use of cannabidiol, the treatment of epilepsy, has significant scientific evidence to support it. Last month, an advisory panel from the US Food and Drug Administration (FDA). UU he unanimously recommended the approval of the CBD Epidiolex medication to treat two rare forms of childhood epilepsy.

It's really the only area where evidence has emerged to the point where the FDA has said it's acceptable to approve a new drug, said Timothy Welty, chairman of the department of clinical sciences at the College of Pharmacy and Science of the Health from Drake University in Des Moines Sera Labs, Iowa.

No comments:

Post a Comment